SG Americas Securities’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$549K Buy
24,303
+5,315
+28% +$118K ﹤0.01% 2130
2025
Q4
$491K Buy
18,988
+3,286
+21% +$78.1K ﹤0.01% 2504
2025
Q3
$405K Buy
15,702
+9,251
+143% +$227K ﹤0.01% 2270
2025
Q2
$154K Sell
6,451
-10,427
-62% -$263K ﹤0.01% 2422
2025
Q1
$419K Sell
16,878
-2,969
-15% -$71.1K ﹤0.01% 1923
2024
Q4
$374K Sell
19,847
-5,407
-21% -$94.9K ﹤0.01% 1606
2024
Q3
$380K Buy
25,254
+12,396
+96% +$212K ﹤0.01% 1938
2024
Q2
$368K Buy
12,858
+9,242
+256% +$263K ﹤0.01% 1854
2024
Q1
$106K Buy
+3,616
New +$111K ﹤0.01% 2517
2023
Q4
Sell
-21,843
Closed -$670K 3353
2023
Q3
$670K Buy
21,843
+5,979
+38% +$216K 0.01% 1549
2023
Q2
$636K Buy
15,864
+5,264
+50% +$218K 0.01% 1291
2023
Q1
$433K Buy
10,600
+7,961
+302% +$317K 0.01% 1827
2022
Q4
$102K Sell
2,639
-6,509
-71% -$317K ﹤0.01% 2714
2022
Q3
$487K Sell
9,148
-7,183
-44% -$399K 0.01% 1573
2022
Q2
$952K Buy
16,331
+4,294
+36% +$281K 0.01% 1343
2022
Q1
$919K Sell
12,037
-15,422
-56% -$1.03M 0.01% 1483
2021
Q4
$1.65M Buy
27,459
+18,445
+205% +$1.02M 0.01% 1246
2021
Q3
$505K Buy
9,014
+2,938
+48% +$169K ﹤0.01% 2499
2021
Q2
$369K Sell
6,076
-11,885
-66% -$752K ﹤0.01% 2079
2021
Q1
$1.26M Sell
17,961
-46,741
-72% -$3.34M 0.01% 1364
2020
Q4
$3.87M Buy
64,702
+30,935
+92% +$1.81M 0.03% 647
2020
Q3
$2.03M Buy
33,767
+30,950
+1,099% +$1.8M 0.02% 724
2020
Q2
$148K Sell
2,817
-5,954
-68% -$249K ﹤0.01% 3107
2020
Q1
$294K Buy
8,771
+3,612
+70% +$150K ﹤0.01% 2247
2019
Q4
$234K Sell
5,159
-2,164
-30% -$91.9K ﹤0.01% 2370
2019
Q3
$279K Sell
7,323
-77,420
-91% -$3.09M ﹤0.01% 2190
2019
Q2
$3.69M Buy
84,743
+81,699
+2,684% +$3.47M 0.03% 687
2019
Q1
$116K Buy
3,044
+540
+22% +$21.1K ﹤0.01% 2966
2018
Q4
$108K Buy
+2,504
New +$117K ﹤0.01% 2699
2017
Q4
Sell
-10,559
Closed -$396K 3511
2017
Q3
$396K Buy
10,559
+4,164
+65% +$168K ﹤0.01% 2024
2017
Q2
$305K Buy
6,395
+3,681
+136% +$171K ﹤0.01% 2162
2017
Q1
$124K Sell
2,714
-13,471
-83% -$582K ﹤0.01% 2829
2016
Q4
$523K Buy
16,185
+8,754
+118% +$292K ﹤0.01% 1667
2016
Q3
$254K Sell
7,431
-1,068
-13% -$41.8K ﹤0.01% 2288
2016
Q2
$287K Buy
8,499
+4,883
+135% +$240K ﹤0.01% 1961
2016
Q1
$192K Buy
3,616
+2,169
+150% +$127K ﹤0.01% 2225
2015
Q4
$111K Sell
1,447
-8,398
-85% -$476K ﹤0.01% 2353
2015
Q3
$405K Buy
9,845
+7,718
+363% +$473K ﹤0.01% 1131
2015
Q2
$150K Buy
2,127
+243
+13% +$19.1K ﹤0.01% 2129
2015
Q1
$167K Sell
1,884
-6,799
-78% -$690K ﹤0.01% 1979
2014
Q4
$770K Buy
8,683
+4,381
+102% +$414K ﹤0.01% 1368
2014
Q3
$417K Buy
4,302
+2,616
+155% +$254K ﹤0.01% 1558
2014
Q2
$155K Buy
+1,686
New +$128K ﹤0.01% 2165
2013
Q4
Sell
-5,301
Closed -$255K 2916
2013
Q3
$255K Buy
+5,301
New +$193K ﹤0.01% 2016

Other funds holding PCRX